LauraPasin (@Laura_Pasin) header
LauraPasin (@Laura_Pasin) profile picture
Joined November 2012
Photo by LauraPasin (@Laura_Pasin)Photo by LauraPasin (@Laura_Pasin)Photo by LauraPasin (@Laura_Pasin)
We've just presented and published a multicenter RCT at #CCR23 and in @JAMA_current! Continuous vs Intermittent Meropenem Administration in Critically Ill Patients with Sepsis: The #MERCYtrial! 🔗 jamanetwork.com/journals/jam… This 🧵 will explain the study in detail /11 #FOAMcc
13
138
6
301
123,544
B1/3 NEW ANTIBIOTIC QUIZ Does the regimen of #meropenem administration (continuous vs intermittent) influence survival in ICU patients with #sepsis or #septicshock?   Stay tuned for #MERCYtrial @DrToddLee @nickmmark @iceman_ex @CritCareReviews @iamyourgasman @FOAMecmo #FOAMcc
46%Continuous better
8%Intermittent better
28%No difference
18%Just wanna see the result
370 votes • Final results
2
12
10
9,797
1-4 Our updated meta-analysis confirmed that low #tidalvolume during #onelungventilation 🔼 P/F ratio, 🔽 PPCs and 🔽 arrhythmias, but 🔼 PaCO2 & no effect on hospital stay sciencedirect.com/science/ar… @JCVAonline @SCVA1997 @scahq @EACTAIC @Laura_Pasin @giovannilandoni @gelysamara
4
7
1
18
3,202
In this meta-analysis by Covello, @Laura_Pasin, @giovannilandoni, and others in @NEJMEvidence, steroids were associated with increased mortality when administered to COVID-19 patients not requiring oxygen. #steroids #COVID19 buff.ly/3Vu4kZI
3
7
1,097
A nice @NEJMEvidence editorial on our article on mortality increase when using #glucorticoids in #covid19 who are not receiving #oxygen teapawt.net/NEJMEvidence/sta… “...under some circumstances, randomized controlled trials can become infeasible as evidence accrues (e.g., randomization to a probable harmful exposure), as in the meta-analysis by Covello et al.” kudos to the authors, especially those who are active on twitter :) @Laura_Pasin @SFresilli @LudhmilaHajjar @azangrillo @SRAnesthesiaICU #medtwitter #Foamed
Meta-analysis is a valuable statistical tool in medical research. In this editorial on a meta-analysis of steroids in Covid-19 patients not on oxygen, Rui Wang, PhD, discusses combining small numbers of randomized clinical trials with observational data. eviden.cc/3ZOETTl

10
22
5,398
“…our meta-analysis shows that administering glucocorticoids in hospitalized patients with Covid-19 not receiving oxygen is likely associated with worse clinical outcomes.” Full study: eviden.cc/3MnrDSA #IDTwitter #ARDS #CriticalCare

3
16
26
5,718
#CritCare #OpenAccess #Propofol may reduce survival in perioperative and critically ill patients. Read the full article: rdcu.be/c9UU8 @jlvincen @ISICEM #FOAMed #FOAMcc
1
19
1
57
20,768
Our latest manouscript sheds new light on treating hospitalized #COVID19 patients not on oxygen therapy! According to our study sistemic glucocordicoids are detrimental in this setting. 🚨 Read our findings in NEJM Evidence and help spread the word! 📢 #research #coronavirus🦠
Just published: “Meta-Analysis of Glucocorticoids for Covid-19 Patients Not Receiving Oxygen,” by Remo Daniel Covello, MD, @giovannilandoni, et al. Read the Original Article: eviden.cc/3MnrDSA #IDTwitter #ARDS #CriticalCare

2
3
667
‼️Going deep into the problem ⚠️Is propofol detrimental for survival❓ Comments and reflection on propofol and survival MA with the authors: Me and @YukiKotani5 👉ccforum.biomedcentral.com/ar… @ITACTAtwits meet the authors TODAY 6.00pm 🔗FREE link itacta.org/ #FOAMcc
#PROPOFOL and survival 🎙️LIVE FREE WEBINAR: @ITACTAtwits MEET THE AUTHORS Authors @YukiKotani5 @alessanro_pruna present @Crit_Care meta-analysis on propofol in periop & ICU settings rdcu.be/c97bq 🗓️April 19, 18:00 (CEST) 👇Link to participate itacta.org/
1
4
9
1,362
🚫 DON’T use glucocorticoids in oxygen-free #COVID19 pts Just published @NEJMEvidence   Guidelines are against glucocorticoids in pts not on O2 but effect on survival remains unclear   Our meta-analysis found that glucocorticoids increase mortality 🔗eviden.cc/3MnrDSA 1/5
3
65
5
168
26,191
Propofol may increase mortality in ICU and perioperative settings🚨 Our new meta-analysis documented statistically significantly higher mortality in the #propofol group than control group Let's go into depth about this provocative result 🧵/7 🔗ccforum.biomedcentral.com/ar… #FOAMcc
27
193
47
521
487,023
YES! it was 2013 when we @Laura_Pasin @azangrillo published a letter in the @NEJM suggesting that #Glutamine supplementation is detrimental for survival of critically ill patients according to multicenter #RCT pubmed.ncbi.nlm.nih.gov/2390…
1
3
8
This article had large media coverage in Italy, was poorly interpreted, and has 1 dangerous message YES non-steroideal antinflammatory agents are ok for patients at home (minor benefits) NO! corticosteroids are dangerous and should not be prescribed at home (increase mortality)
4
14
30
LET’S REDUCE TRANSUSION BY 20% WITH #TRANEXAMIC acid #TXA 1/ We helped @PHRIresearch in conducting the #POISE3 #RCT published in the @NEJM and presented #ACC22 also #mortality is reduced by 10% in this @NEJM #RCT on #tranexamic acid. This is probably the most important finding
Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo. #ACC22 nej.md/3IMTKoz
2
15
2
21
Proud to join @FrontiersIn Anesthesiology as Associate Editor. With an amazing editorial team, this new journal will help shape the future of anesthesiology. Find out more: frontiersin.org/journals/ane…
4
🫀ANESTHETIC MYOCARDIAL PROTECTION resurrection? Dozens of colleagues and studies worldwide found a cardioprotective effect of volatile agents in laboratory, animal and human studies over the last decades. We re-analyzed our large #MYRIADTrial ➡️ jcvaonline.com/article/S1053… #FOAMcc
2
11
3
19